| Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland SJ McGurnaghan, A Weir, J Bishop, S Kennedy, LAK Blackbourn, ... The lancet Diabetes & endocrinology 9 (2), 82-93, 2021 | 326 | 2021 |
| Incidence of hospitalization for heart failure and case-fatality among 3.25 million people with and without diabetes mellitus DA McAllister, SH Read, J Kerssens, S Livingstone, S McGurnaghan, ... Circulation 138 (24), 2774-2786, 2018 | 185 | 2018 |
| Genome-wide association study of diabetic kidney disease highlights biology involved in glomerular basement membrane collagen RM Salem, JN Todd, N Sandholm, JB Cole, WM Chen, D Andrews, ... Journal of the American Society of Nephrology 30 (10), 2000-2016, 2019 | 152 | 2019 |
| Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission SH Wild, JJ Walker, JR Morling, DA McAllister, HM Colhoun, B Farran, ... Diabetes care 41 (2), 341-347, 2018 | 129 | 2018 |
| Glycosylation of immunoglobulin G is regulated by a large network of genes pleiotropic with inflammatory diseases L Klarić, YA Tsepilov, CM Stanton, M Mangino, TT Sikka, T Esko, ... Science advances 6 (8), eaax0301, 2020 | 116 | 2020 |
| N-glycan profile and kidney disease in type 1 diabetes ML Bermingham, M Colombo, SJ McGurnaghan, LAK Blackbourn, ... Diabetes care 41 (1), 79-87, 2018 | 102 | 2018 |
| Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study T Vadiveloo, W Jeffcoate, PT Donnan, HC Colhoun, S McGurnaghan, ... Diabetologia 61, 2590-2597, 2018 | 81 | 2018 |
| Clinical impact of residual C-peptide secretion in type 1 diabetes on glycemia and microvascular complications A Jeyam, H Colhoun, S McGurnaghan, L Blackbourn, TJ McDonald, ... Diabetes Care 44 (2), 390-398, 2021 | 79 | 2021 |
| Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study S Bell, B Farran, S McGurnaghan, RJ McCrimmon, GP Leese, JR Petrie, ... BMC nephrology 18, 1-8, 2017 | 71 | 2017 |
| Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis S McGurnaghan, LAK Blackbourn, E Mocevic, U Haagen Panton, ... Diabetic Medicine 36 (6), 718-725, 2019 | 70 | 2019 |
| Rapid epidemiological analysis of comorbidities and treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): a population-based case-control study PM McKeigue, A Weir, J Bishop, SJ McGurnaghan, S Kennedy, ... PLoS Medicine 17 (10), e1003374, 2020 | 69 | 2020 |
| Relation of incident type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland PM McKeigue, S McGurnaghan, L Blackbourn, LE Bath, DA McAllister, ... Diabetes care 46 (5), 921-928, 2023 | 64 | 2023 |
| Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016 C Mair, W Wulaningsih, A Jeyam, S McGurnaghan, L Blackbourn, ... Diabetologia 62, 1375-1384, 2019 | 55 | 2019 |
| Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study PM McKeigue, S Kennedy, A Weir, J Bishop, SJ McGurnaghan, ... BMC medicine 19, 1-11, 2021 | 52 | 2021 |
| Public Health Scotland COVID-19 Health Protection Study Group; Scottish Diabetes Research Network Epidemiology Group. Risks of and risk factors for COVID-19 disease in people … SJ McGurnaghan, A Weir, J Bishop, S Kennedy, LAK Blackbourn, ... Lancet Diabetes Endocrinol 9 (2), 82-93, 2021 | 49 | 2021 |
| Persistent C-peptide secretion in type 1 diabetes and its relationship to the genetic architecture of diabetes PM McKeigue, A Spiliopoulou, S McGurnaghan, M Colombo, ... BMC medicine 17, 1-11, 2019 | 49 | 2019 |
| The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study SJ McGurnaghan, L Brierley, TM Caparrotta, PM McKeigue, ... Diabetologia 62, 621-632, 2019 | 41 | 2019 |
| Biomarker panels associated with progression of renal disease in type 1 diabetes M Colombo, E Valo, SJ McGurnaghan, N Sandholm, LAK Blackbourn, ... Diabetologia 62, 1616-1627, 2019 | 40 | 2019 |
| Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes M Colombo, SJ McGurnaghan, LAK Blackbourn, RN Dalton, D Dunger, ... Diabetologia 63, 788-798, 2020 | 38 | 2020 |
| Diabetic neuropathy is a substantial burden in people with type 1 diabetes and is strongly associated with socioeconomic disadvantage: a population-representative study from … A Jeyam, SJ McGurnaghan, LAK Blackbourn, JM McKnight, F Green, ... Diabetes Care 43 (4), 734-742, 2020 | 36 | 2020 |
